Managing Cough in Idiopathic Pulmonary Fibrosis

被引:25
作者
Wakwaya, Yosafe [1 ]
Ramdurai, Deepa [2 ]
Swigris, Jeffrey J. [3 ]
机构
[1] Baylor Univ, Med Ctr, Pulm & Crit Care Med, Dallas, TX USA
[2] Univ Penn, Philadelphia, PA USA
[3] Natl Jewish Hlth, Interstitial Lung Dis Program, Div Pulm Crit Care & Sleep Med, Denver, CO 80206 USA
关键词
cough; idiopathic pulmonary fibrosis; pulmonary fibrosis; REFRACTORY CHRONIC COUGH; GASTROESOPHAGEAL-REFLUX; CHEST GUIDELINE; DOUBLE-BLIND; PREVALENCE; ADULTS; ACID; MANAGEMENT; FREQUENCY; IMPEDANCE;
D O I
10.1016/j.chest.2021.05.071
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In many studies, more than one-half of patients with idiopathic pulmonary fibrosis (IPF) endorse cough. In IPF (as in other conditions), when chronic, cough may be frustrating and lead to significant impairments in quality of life. In patients with IPF, comorbid conditions such as gastroesophageal reflux can cause or contribute to cough; when stemming from IPF itself, chronic cough likely arises from multiple mechanisms including mechanical and neurosensory changes. In this article, we review our approach at attempting to identify causes of chronic cough in patients with IPF; these include gastroesophageal reflux disease or upper airway cough syndrome and IPF itself. We cursorily summarize the current evidence for the treatment of chronic cough in IPF, briefly review data on the treatment of unexplained chronic cough and extrapolate it to the treatment of refractory cough in IPF, but we focus our attention on our approaches to evaluation and management, recognizing that some may not be supported by a robust cache of data. CHEST 2021; 160(5):1774-1782
引用
收藏
页码:1774 / 1782
页数:9
相关论文
共 56 条
[1]   Nasal Irrigation as Treatment in Sinonasal Symptoms Relief: A Review of Its Efficacy and Clinical Applications [J].
Abdullah, Baharudin ;
Periasamy, Chenthilnathan ;
Ismail, Rushdan .
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2019, 71 (Suppl 3) :1718-1726
[2]   Rhinorrhea, cough and fatigue in patients taking sitagliptin [J].
Baraniuk J.N. ;
Jamieson M.J. .
Allergy, Asthma & Clinical Immunology, 6 (1)
[3]   The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis [J].
Bargagli, Elena ;
Di Masi, Maria ;
Perruzza, Marco ;
Vietri, Lucia ;
Bergantini, Laura ;
Torricelli, Elena ;
Biadene, Giulia ;
Fontana, Giovanni ;
Lavorini, Federico .
INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (01) :39-43
[4]   Treatment of Interstitial Lung Disease Associated Cough CHEST Guideline and Expert Panel Report [J].
Birring, Surinder S. ;
Kavanagh, Joanne E. ;
Irwin, Richard S. ;
Keogh, Karina A. ;
Lim, Kaiser G. ;
Ryu, Jay H. .
CHEST, 2018, 154 (04) :904-917
[5]   A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial [J].
Birring, Surinder S. ;
Wijsenbeek, Marlies S. ;
Agrawal, Sanjay ;
van den Berg, Jan W. K. ;
Stone, Helen ;
Maher, Toby M. ;
Tutuncu, Ahmet ;
Morice, Alyn H. .
LANCET RESPIRATORY MEDICINE, 2017, 5 (10) :806-815
[6]  
Birring Surinder S, 2007, Cough, V3, P7
[7]   Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue [J].
Caminati, Antonella ;
Lonati, Chiara ;
Cassandro, Roberto ;
Elia, Davide ;
Pelosi, Giuseppe ;
Torre, Olga ;
Zompatori, Maurizio ;
Uslenghi, Elisabetta ;
Harari, Sergio .
EUROPEAN RESPIRATORY REVIEW, 2019, 28 (153)
[8]  
Center for Drug Evaluation and Research US Food and Drug Administration, 2014, VOIC PAT SER REP US
[9]   Cough in obstructive sleep apnoea [J].
Chan, Kevin ;
Alvin, Ing ;
Birring, Surinder S. .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 35 :129-131
[10]   Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases [J].
Cheng, Jasmine Z. ;
Wilcox, Pearce G. ;
Glaspole, Ian ;
Corte, Tamera J. ;
Murphy, Darra ;
Hague, Cameron J. ;
Ryerson, Christopher J. .
RESPIROLOGY, 2017, 22 (08) :1592-1597